Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

SHA:603229 Revenue

Zhejiang Ausun Pharmaceutical had revenue of 308.67M CNY in the quarter ending March 31, 2026, with 0.66% growth. This brings the company's revenue in the last twelve months to 794.80M, down -0.78% year-over-year. In the year 2025, Zhejiang Ausun Pharmaceutical had annual revenue of 792.76M, down -0.32%.

• Revenue (ttm): 794.80M
• Revenue Growth: -0.78%
• P/S Ratio: 8.43
• Revenue / Employee: 598.49K
• Employees: 1,328
• Market Cap: 6.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	792.76M	-2.53M	-0.32%
Dec 31, 2024	795.29M	-21.48M	-2.63%
Dec 31, 2023	816.77M	52.22M	6.83%
Dec 31, 2022	764.55M	194.85M	34.20%
Dec 31, 2021	569.70M	160.45M	39.21%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error